Enzo Biochem, Inc. (ENZ)
USD 0.31
(-17.77%)
USD 0.31
(-17.77%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 189 Thousand USD | -94.49% |
| 2023 | 3.42 Million USD | -79.64% |
| 2022 | 16.84 Million USD | -11.45% |
| 2021 | 19.02 Million USD | -10.79% |
| 2020 | 21.32 Million USD | 363.28% |
| 2019 | 4.6 Million USD | 1203.97% |
| 2018 | 353 Thousand USD | -38.39% |
| 2017 | 573 Thousand USD | -36.26% |
| 2016 | 899 Thousand USD | 56.89% |
| 2015 | 573 Thousand USD | -19.64% |
| 2014 | 713 Thousand USD | -7.88% |
| 2013 | 774 Thousand USD | 504.69% |
| 2012 | 128 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 1.83 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 100 Thousand USD | -97.87% |
| 1995 | 4.7 Million USD | 9.3% |
| 1994 | 4.3 Million USD | 2.38% |
| 1993 | 4.2 Million USD | 0.0% |
| 1992 | 4.2 Million USD | -6.67% |
| 1991 | 4.5 Million USD | -90.17% |
| 1990 | 45.8 Million USD | -6.91% |
| 1989 | 49.2 Million USD | 1.86% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 234 Thousand USD | 6.85% |
| 2024 Q1 | 3.19 Million USD | -93.61% |
| 2024 Q4 | 189 Thousand USD | 5.0% |
| 2024 Q3 | 180 Thousand USD | -23.08% |
| 2023 Q1 | 15.95 Million USD | -5.28% |
| 2023 Q2 | 11.42 Million USD | -28.42% |
| 2023 Q4 | 3.42 Million USD | -68.77% |
| 2023 FY | 3.42 Million USD | -79.64% |
| 2023 Q3 | 10.98 Million USD | -3.85% |
| 2022 Q2 | 17.54 Million USD | -3.94% |
| 2022 Q4 | 16.84 Million USD | -1.0% |
| 2022 FY | 16.84 Million USD | -11.45% |
| 2022 Q1 | 18.26 Million USD | -3.97% |
| 2022 Q3 | 17.01 Million USD | -3.04% |
| 2021 Q1 | 20.7 Million USD | -2.91% |
| 2021 Q4 | 19.02 Million USD | -2.15% |
| 2021 Q2 | 20.13 Million USD | -2.73% |
| 2021 Q3 | 19.44 Million USD | -3.46% |
| 2021 FY | 19.02 Million USD | -10.79% |
| 2020 Q2 | 22.44 Million USD | -4.73% |
| 2020 Q3 | 21.92 Million USD | -2.3% |
| 2020 Q1 | 23.55 Million USD | 411.77% |
| 2020 Q4 | 21.32 Million USD | -2.74% |
| 2020 FY | 21.32 Million USD | 363.28% |
| 2019 Q4 | 4.6 Million USD | 8.69% |
| 2019 Q1 | 320 Thousand USD | -9.35% |
| 2019 FY | 4.6 Million USD | 1203.97% |
| 2019 Q3 | 4.23 Million USD | -5.13% |
| 2019 Q2 | 4.46 Million USD | 1295.0% |
| 2018 Q3 | 404 Thousand USD | -18.38% |
| 2018 FY | 353 Thousand USD | -38.39% |
| 2018 Q1 | 533 Thousand USD | -6.98% |
| 2018 Q2 | 495 Thousand USD | -7.13% |
| 2018 Q4 | 353 Thousand USD | -12.62% |
| 2017 Q1 | 803 Thousand USD | -10.68% |
| 2017 Q2 | 698 Thousand USD | -13.08% |
| 2017 Q3 | 657 Thousand USD | -5.87% |
| 2017 FY | 573 Thousand USD | -36.26% |
| 2017 Q4 | 573 Thousand USD | -12.79% |
| 2016 Q4 | 899 Thousand USD | -11.6% |
| 2016 Q3 | 1.01 Million USD | -9.6% |
| 2016 Q2 | 1.12 Million USD | 104.55% |
| 2016 FY | 899 Thousand USD | 56.89% |
| 2016 Q1 | 550 Thousand USD | -4.01% |
| 2015 Q1 | 647 Thousand USD | -9.26% |
| 2015 Q4 | 573 Thousand USD | -8.32% |
| 2015 Q2 | 672 Thousand USD | 3.86% |
| 2015 FY | 573 Thousand USD | -19.64% |
| 2015 Q3 | 625 Thousand USD | -6.99% |
| 2014 Q1 | 775 Thousand USD | 0.13% |
| 2014 FY | 713 Thousand USD | -7.88% |
| 2014 Q2 | 737 Thousand USD | -4.9% |
| 2014 Q3 | 710 Thousand USD | -3.66% |
| 2014 Q4 | 713 Thousand USD | 0.42% |
| 2013 Q3 | 803 Thousand USD | 4.97% |
| 2013 Q4 | 774 Thousand USD | -3.61% |
| 2013 FY | 774 Thousand USD | 504.69% |
| 2013 Q1 | 100 Thousand USD | -21.88% |
| 2013 Q2 | 765 Thousand USD | 665.0% |
| 2012 FY | 128 Thousand USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | 128 Thousand USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | 1.83 Million USD | 0.0% |
| 2009 Q2 | 1.39 Million USD | 0.0% |
| 2009 Q3 | 823 Thousand USD | -41.17% |
| 2009 Q4 | 1.83 Million USD | 123.33% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | -100.0% |
| 2005 Q2 | 300 Thousand USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1997 Q1 | 100 Thousand USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1996 FY | 100 Thousand USD | -97.87% |
| 1996 Q1 | 4.7 Million USD | 0.0% |
| 1996 Q3 | 4.7 Million USD | -2.08% |
| 1996 Q4 | 100 Thousand USD | -97.87% |
| 1996 Q2 | 4.8 Million USD | 2.13% |
| 1995 Q3 | 4.4 Million USD | -2.22% |
| 1995 Q1 | 4.5 Million USD | 4.65% |
| 1995 Q2 | 4.5 Million USD | 0.0% |
| 1995 FY | 4.7 Million USD | 9.3% |
| 1995 Q4 | 4.7 Million USD | 6.82% |
| 1994 Q2 | 4.2 Million USD | 5.0% |
| 1994 Q1 | 4 Million USD | -4.76% |
| 1994 FY | 4.3 Million USD | 2.38% |
| 1994 Q4 | 4.3 Million USD | 2.38% |
| 1994 Q3 | 4.2 Million USD | 0.0% |
| 1993 Q2 | 4.3 Million USD | 2.38% |
| 1993 Q1 | 4.2 Million USD | 0.0% |
| 1993 FY | 4.2 Million USD | 0.0% |
| 1993 Q4 | 4.2 Million USD | -2.33% |
| 1993 Q3 | 4.3 Million USD | 0.0% |
| 1992 Q4 | 4.2 Million USD | -16.0% |
| 1992 Q3 | 5 Million USD | 0.0% |
| 1992 Q1 | 5.1 Million USD | 13.33% |
| 1992 FY | 4.2 Million USD | -6.67% |
| 1992 Q2 | 5 Million USD | -1.96% |
| 1991 Q1 | 46 Million USD | 0.44% |
| 1991 Q3 | 14.5 Million USD | -64.89% |
| 1991 Q4 | 4.5 Million USD | -68.97% |
| 1991 Q2 | 41.3 Million USD | -10.22% |
| 1991 FY | 4.5 Million USD | -90.17% |
| 1990 Q4 | 45.8 Million USD | -7.29% |
| 1990 FY | 45.8 Million USD | -6.91% |
| 1990 Q2 | 49.3 Million USD | 0.0% |
| 1990 Q3 | 49.4 Million USD | 0.2% |
| 1990 Q1 | 49.3 Million USD | 0.2% |
| 1989 FY | 49.2 Million USD | 1.86% |
| 1989 Q4 | 49.2 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 2.73 Billion USD | 99.993% |
| Charles River Laboratories International, Inc. | 3.06 Billion USD | 99.994% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 99.996% |
| Danaher Corporation | 17.66 Billion USD | 99.999% |
| IQVIA Holdings Inc. | 12.95 Billion USD | 99.999% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 99.995% |
| Mettler-Toledo International Inc. | 1.88 Billion USD | 99.99% |
| Qiagen N.V. | 921.82 Million USD | 99.979% |
| Revvity, Inc. | 3.17 Billion USD | 99.994% |
| Thermo Fisher Scientific Inc. | 31.3 Billion USD | 99.999% |
| Waters Corporation | 2.3 Billion USD | 99.992% |